201 related articles for article (PubMed ID: 37892209)
1. Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer.
Chutani N; Ragula S; Syed K; Pakala SB
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892209
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic functions of MORC2 in lipogenesis and adipogenesis.
Sánchez-Solana B; Li DQ; Kumar R
Biochim Biophys Acta; 2014 Feb; 1843(2):316-26. PubMed ID: 24286864
[TBL] [Abstract][Full Text] [Related]
3. Microrchidia 2/histone deacetylase 1 complex regulates E-cadherin gene expression and function.
Thomas L; Chutani N; R K; Nair AS; Yellapu NK; Karyala P; Pakala SB
Biochem J; 2023 Oct; 480(20):1675-1691. PubMed ID: 37815456
[TBL] [Abstract][Full Text] [Related]
4. MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration.
Guddeti RK; Pacharla H; Yellapu NK; Karyala P; Pakala SB
Med Oncol; 2023 Feb; 40(3):102. PubMed ID: 36802305
[TBL] [Abstract][Full Text] [Related]
5. MORC2 Interactome: Its Involvement in Metabolism and Cancer.
Guddeti RK; Chutani N; Pakala SB
Biophys Rev; 2021 Aug; 13(4):507-514. PubMed ID: 34471435
[TBL] [Abstract][Full Text] [Related]
6. MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells.
Saroha HS; Kumar Guddeti R; Jacob JP; Kumar Pulukuri K; Karyala P; Pakala SB
Med Oncol; 2022 Jun; 39(9):135. PubMed ID: 35727356
[TBL] [Abstract][Full Text] [Related]
7. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
8. Dimerization of MORC2 through its C-terminal coiled-coil domain enhances chromatin dynamics and promotes DNA repair.
Xie HY; Zhang TM; Hu SY; Shao ZM; Li DQ
Cell Commun Signal; 2019 Dec; 17(1):160. PubMed ID: 31796101
[TBL] [Abstract][Full Text] [Related]
9. The chromatin modifier MORC2 affects glucose metabolism by regulating the expression of lactate dehydrogenase A through a feed forward loop with c-Myc.
Guddeti RK; Thomas L; Kannan A; Karyala P; Pakala SB
FEBS Lett; 2021 May; 595(9):1289-1302. PubMed ID: 33626175
[TBL] [Abstract][Full Text] [Related]
10. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ
Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866
[No Abstract] [Full Text] [Related]
11. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
12. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response.
Li DQ; Nair SS; Ohshiro K; Kumar A; Nair VS; Pakala SB; Reddy SD; Gajula RP; Eswaran J; Aravind L; Kumar R
Cell Rep; 2012 Dec; 2(6):1657-69. PubMed ID: 23260667
[TBL] [Abstract][Full Text] [Related]
13. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
14. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
15. Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.
Liao XH; Zhang Y; Dong WJ; Shao ZM; Li DQ
Oncotarget; 2017 Nov; 8(58):97941-97954. PubMed ID: 29228664
[TBL] [Abstract][Full Text] [Related]
16. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
17. MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
Pan Z; Ding Q; Guo Q; Guo Y; Wu L; Wu L; Tang M; Yu H; Zhou F
Int J Oncol; 2018 Jul; 53(1):59-72. PubMed ID: 29620211
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic MORC2 in cancer development and beyond.
Zhang S; Guo A; Wang H; Liu J; Dong C; Ren J; Wang G
Genes Dis; 2024 Mar; 11(2):861-873. PubMed ID: 37692502
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
20. Aberrant high expression level of MORC2 is a common character in multiple cancers.
Ding QS; Zhang L; Wang BC; Zeng Z; Zou XQ; Cao PB; Zhou GM; Tang M; Wu L; Wu LL; Yu HG; Guo Y; Zhou FX
Hum Pathol; 2018 Jun; 76():58-67. PubMed ID: 29555576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
